scPharmaceuticals Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 24, 2025

scPharmaceuticals Inc. Enterprise Value to EBITDA (EV/EBITDA) is NA on July 24, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • scPharmaceuticals Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -2.91 on July 24, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • scPharmaceuticals Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -3.97 on July 24, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • scPharmaceuticals Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -3.53.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization